🟢 Biovie is trading 7.5% up in pre-market without a confirmed catalyst

Biovie is trading 7.5% up at $1.29 before the October 19, 2026 market open; no fresh company announcement or confirmed catalyst explaining the move was found.

• Biovie closed at $1.20 on October 16.
• The company is presenting Phase 2 Parkinson’s and Long COVID findings at the American Neurological Association meeting. The Parkinson’s poster is scheduled for October 19; this was announced October 14.
• Supplied sector context points to biotech weakness, not a clear explanation for Biovie’s rise.